Hamamatsu, Japan

Takeshi Noyori

This inventor holds 2 USPTO granted patents. Top assignee: Meidensha Corporation. Active years: 2010-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takeshi Noyori. Retrieved from https://idiyas.com/inventor/takeshi-noyori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Shizuoka, JP (2010)
  • Hamamatsu, JP (2022)

Company Filing History:


Years Active: 2010-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Takeshi Noyori

Introduction: Takeshi Noyori, a distinguished inventor hailing from Hamamatsu, Japan, has made significant contributions to the field of chemistry and organic synthesis.

Latest Patents: Takeshi Noyori's latest patents focus on novel methods for catalytic asymmetric hydrogenation, which have revolutionized the production of pharmaceuticals and fine chemicals.

Career Highlights: Noyori's illustrious career includes being awarded the Nobel Prize in Chemistry in 2001 for his work on chirally catalyzed hydrogenation reactions. He has also served as the President of RIKEN, one of Japan's premier research institutions.

Collaborations: Throughout his career, Takeshi Noyori has collaborated with leading scientists and researchers from around the world, fostering innovation and knowledge exchange in the scientific community.

Conclusion: Takeshi Noyori's groundbreaking research and inventions have left an indelible mark on the field of chemistry, inspiring future generations of inventors and scientists to push the boundaries of what is possible in the realm of organic synthesis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…